Magda Mahmoud Badawy
Cairo, Egypt
NCT Number: NCT04051762
The investigators hypothesize that there is a growing trend of the feasibility of HFNC as an alternative to other forms of non-invasive ventilation mechanism to provide continuous distending pressure to preterm infants. However, there remains uncertainty about the efficacy and safety of HFNC in this population.
Looking for future studies?
Notify Me1 day–28 day
All sexes
Observational
Cairo, Egypt
Our primary outcome is to determine whether postextubation respiratory support via heated humidified high-flow nasal cannula results in a greater proportion of infants younger than 34 weeks gestation being successfully extubated after a period of endotracheal positive pressure ventilation compared with conventional (NCPAP).
The following study will be conducted in the neonatal intensive care unit (NICU) of Gynecology and Obstetric department of Kasr El Aini hospital and neonatal intensive care unit of Military Hospital throughout a time interval of at least 6 months for a minimum of 100 preterm infants.
Infants will be eligible for the study if they born at less than 34 weeks' gestation, required endotracheal intubation and positive pressure ventilation, and considered ready for extubation by the clinical team.
The investigators will assign extubation of preterm ventilated infants (50 preterm infant) in NICU of Military Hospital into HHFNC and extubation of preterm ventilated infants (50 preterm infant) in (NICU) of Gynecology and Obstetric department of Kasr El Aini hospital into NCPAP (50 preterm infant).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
•Infants born at a gestational age of less than 34 weeks, receiving mechanical ventilation through an endotracheal tube.
Exclusion criteria
High flow nasal cannula
Time frame: through study completion, an average of 1 year
compare successful extubation of preterm (less than 34 weeks) into high flow nasal cannula versus continues positive airway pressure.
Time frame: through study completion, an average of 1 year
Secondary outcomes include the following:
Ramy Saleh Morsy
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06207994
Lung Diseases, Neonatal Respiratory Distress
Prague, Czechia
View Trial DetailsNCT06356909
Lung Diseases, Neonatal Respiratory Distress
Créteil, France
View Trial DetailsNCT05257499
Lung Diseases, Neonatal Respiratory Distress
Beirut, Lebanon
View Trial DetailsNCT05274386
Lung Diseases, Neonatal Respiratory Distress
Prague, Czechia
View Trial Details